Login
$CTMX
$2.02 +$0.03 (1.76%) After hours

Company Executives

Officer Age In this role Joined Source
Sean A. McCarthy Also a director
Chief Executive Officer and Chairman of the Board
59 Not stated Not stated
Christopher (Chris) W. Ogden
Senior Vice President, Chief Financial Officer
42 Since 2024
2 years
2021
Marcia P. Belvin
Senior Vice President, Chief Scientific Officer
59 Since 2022
4 years
2018
Yu-Waye (Wayne) Chu
Senior Vice President, Chief Medical Officer
58 Since 2023
3 years
2023
Rachael Lester
Senior Vice President, Chief Business Officer
48 Since 2025
1 year
2025
Alejandra Carvajal
Chief Legal Officer
Title from the Form 3 dated Aug 3, 2026
Not stated Not stated Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 30, 2026 · updated by the 8-K of Jul 27, 2026

Directors
9
serving now
Independent
7 of 8
stated in the proxy; 1 not stated
Average tenure
6.3 years
from year joined
Director On board Independent Committees Other public boards 2025 pay Source
James R. Meyers
2018
8 years
Independent None stated Sangamo Therapeutics, Inc. $139,514
Halley Gilbert
2020
6 years
Independent
Audit
Arcutis Biotherapeutics, Inc., Vaxcyte, Inc. $143,014
Alan Ashworth, Ph.D.
2021
5 years
Independent
Nominating and Corporate Governance
None stated $131,514
Elaine V. Jones, Ph.D.
Not stated Independent
Compensation Nominating and Corporate Governance
None stated $137,514
Sean A. McCarthy, D. Phil.
Not stated Not independent None stated None stated Not stated
Mani Mohindru, Ph.D.
Not stated Independent
Audit
None stated $136,514
Matthew P. Young
Not stated Independent None stated None stated $167,514
Zhen Su, M.D., M.B.A.
Not stated Independent
Compensation
None stated Not stated
Charles Fuchs Joined Jul 24, 2026
- - - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support